F-group (family)

316.1.1.13 RelA_SpoT

Ligands and drugs

170
Member domains
43
with ligand contacts (≤ 4 Å)
25.3% of members
38
with DrugDomain annotations
22.4% of members
24
with a DrugBank compound
14.1% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 316.1.1.13 belongs to X-group 316 Nucleotidyltransferase-like, which binds 7.3 ligand superclasses per 20 proteins, narrower than 56% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02596APCalpha,beta-Methyleneadenosine 5'-triphosphate16
DB04137GTPGuanosine-5'-Triphosphate2
DB04315GDPGuanosine-5'-Diphosphate2
DB00131AMPAdenosine phosphate1

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION21
APCDIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER16
0O2guanosine 5'-(tetrahydrogen triphosphate) 3'-(trihydrogen diphosphate)10
CLCHLORIDE ION7
FEmetalFE (III) ION2
FE2metalFE (II) ION2
GDPGUANOSINE-5'-DIPHOSPHATE2
GTPGUANOSINE-5'-TRIPHOSPHATE2
IODIODIDE ION2
AMPADENOSINE MONOPHOSPHATE1
ATPADENOSINE-5'-TRIPHOSPHATE1
GN3[[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl]oxy-oxidanyl-phosphoryl]amino]phosphonic acid1
MNmetalMANGANESE (II) ION1
NAmetalSODIUM ION1
VF5[[(3~{a}~{R},4~{R},6~{R},6~{a}~{R})-4-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-2-oxidanyl-2-oxidanylidene-3~{a},4,6,6~{a}-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-6-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate1